TipRanks
Cirtran Corp (CIRX)
OTHER OTC:CIRX
US Market
Want to see CIRX full AI Analyst Report?

Cirtran (CIRX) AI Stock Analysis

2 Followers

Top Page

CIRX

Cirtran

(OTC:CIRX)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - Gpt-5.6Sol)
Rating:43Neutral
Price Target:
$0.02
▼(-42.50% Downside)
Action:Reiterated
Date:09/25/26
The score is held down primarily by weak financial performance driven by deeply negative equity and persistent negative operating/free cash flow, despite improving revenue growth and solid gross margins. Technicals are also unfavorable with price below key moving averages and a negative MACD, only partially offset by an RSI near oversold. Valuation appears optically cheap due to an extremely low P/E, but fundamentals limit the confidence in that signal.
Positive Factors
Revenue Growth
Improving TTM revenue demonstrates stronger recent demand for the company’s services and provides a better base for operating leverage. If sustained, this growth can expand customer activity and support reinvestment, although profitability must improve for the benefit to become durable.
Negative Factors
Deeply Negative Equity
Deeply negative equity signals a severely impaired capital structure and limits the company’s financial flexibility. It can make future financing more difficult or costly, increases solvency risk, and leaves less balance-sheet capacity to absorb operating setbacks or fund growth internally.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Improving TTM revenue demonstrates stronger recent demand for the company’s services and provides a better base for operating leverage. If sustained, this growth can expand customer activity and support reinvestment, although profitability must improve for the benefit to become durable.
Read all positive factors

Cirtran (CIRX) vs. SPDR S&P 500 ETF (SPY)

Cirtran Business Overview & Revenue Model

Company Description
CirTran Corporation provides manufacturing, marketing, distribution, and technology services for consumer products, including tobacco products, medical devices, and beverages worldwide. The company manufactures, distributes, and sells condoms, ele...
How the Company Makes Money
CirTran’s revenue model is primarily based on charging customers for outsourced operational services. This typically includes (1) electronics manufacturing services (EMS) fees for contract manufacturing, assembly, testing, and related production a...

Cirtran Financial Statement Overview

Summary
Revenue growth is improving (TTM ~$4.8M, +26.2%) with solid gross margin (~45%), but overall financial quality is weak. Stockholders’ equity is deeply negative (TTM ~-$23.0M), and both operating cash flow and free cash flow are negative (TTM ~-$0.59M), indicating ongoing cash burn and elevated solvency/liquidity risk. Earnings have also been volatile, reducing confidence in durability.
Income Statement
38
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
BreakdownTTMMar 2026Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.83M3.13M1.30M1.62M1.72M2.92M
Gross Profit2.27M1.54M838.64K1.01M1.02M1.90M
EBITDA414.47K276.37K-1.75M221.70K-562.15K-126.73K
Net Income2.13M-701.63K-2.63M20.29M-1.35M-627.38K
Balance Sheet
Total Assets2.60M2.51M1.53M1.85M2.00M1.46M
Cash, Cash Equivalents and Short-Term Investments158.14K9.59K30.38K0.0018.08K5.47K
Total Debt3.49M3.43M3.36M3.22M3.16M3.22M
Total Liabilities25.60M27.62M25.94M23.63M44.07M42.03M
Stockholders Equity-22.99M-25.11M-24.41M-21.78M-42.07M-40.56M
Cash Flow
Free Cash Flow-586.50K-1.34M-46.35K-81.02K159.30K340.66K
Operating Cash Flow-586.50K-1.34M-46.35K-72.61K159.30K344.46K
Investing Cash Flow0.000.0015.40K-8.41K0.00-3.80K
Financing Cash Flow740.30K1.35M30.95K62.94K-146.69K-443.33K

Cirtran Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.04
Price Trends
50DMA
0.03
Negative
100DMA
0.03
Negative
200DMA
0.03
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
32.11
Neutral
STOCH
57.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CIRX, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.03, and above the 200-day MA of 0.03, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 32.11 is Neutral, neither overbought nor oversold. The STOCH value of 57.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CIRX.

Cirtran Risk Analysis

Cirtran disclosed 16 risk factors in its most recent earnings report. Cirtran reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Cirtran Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$290.12M18.0037.92%16.21%11.24%31.12%
66
Neutral
$144.86M197.300.29%3.42%-57.96%75.86%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
59
Neutral
$278.30M-3.98-27.83%4.15%5.09%14.61%
55
Neutral
$852.42M-5.48-21.01%214.04%8.37%51.01%
53
Neutral
$446.12M71.791.27%―25.45%―
43
Neutral
$187.93K0.09-8.82%―336.70%―
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CIRX
Cirtran
0.02
<0.01
60.00%
CODI
Compass Diversified Holdings
11.25
4.53
67.41%
NNBR
NN
3.67
1.50
69.12%
RCMT
Rcm Technologies
40.47
13.46
49.83%
TRC
Tejon Ranch Company
16.45
0.36
2.24%
TUSK
Mammoth Energy Services
2.98
0.55
22.63%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 25, 2026